Work

A Policy Model to Evaluate the Benefits, Risks and Costs of Warfarin Pharmacogenomic Testing

Year: 2009

Type: article

Source: PharmacoEconomics

DOI: 10.2165/11318240-000000000-00000

Authors: Lisa M. Meckley, James M. Gudgeon, Jeffrey L. Anderson, Marc S. Williams, David L. Veenstra

Institutions: University of Washington, Intermountain Healthcare

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: University of Washington, Centers for Disease Control and Prevention

Award: Risk-Benefit Framework for Genetic Tests

OpenAlex ID: W2059533196

FWCI: 6.972

Cites: 36

Cited by: 97

Related to: 10